血管内超声测斑块旋切术后管腔获得及对中期结果的影响
本研究前瞻性纳入156例下肢血运重建(145例患者),用血管内超声(IVUS)评估不同斑块旋切装置即刻管腔获得百分比,并随访30天双功超声(DUS)及中期临床结果。斑块旋切后中位管腔获得26.4%,不同装置间相似,胫动脉高于股腘动脉(P=0.009)。管腔获得程度未影响临床驱动的靶病变血运重建(cdTLR)。
要点
- 斑块旋切后中位管腔获得26.4%,胫动脉显著高于股腘动脉。
- 30天DUS显示残余/再狭窄>70%者仅2.3%,股腘动脉支架置入率22.2%,胫动脉未置入支架。
- 管腔获得程度与cdTLR无关,cdTLR与初始闭塞、病变长度及支架内再狭窄相关。
核心结论
- 斑块旋切可稳定获得中位26.4%的管腔获得,不同装置间相似且取决于基线血管尺寸。
- 本系列中支架置入不频繁,胫动脉位置未置入支架。
- cdTLR不受钙化程度或斑块旋切所致管腔获得百分比影响。
- 多数患者Rutherford分级改善,开放手术和截肢率低,且仅限于慢性肢体威胁性缺血患者。
研究设计与样本
- 前瞻性收集156例连续下肢血运重建(145例独特患者,11例双侧分期干预)的数据。
- 斑块旋切后均行球囊血管成形术,选择性使用支架。
- 干预指征为症状(Rutherford 3-6级)联合IVUS评估的70%面积狭窄病变。
- IVUS识别病变长度、钙化及斑块旋切前后狭窄百分比,差值代表斑块旋切 alone 的管腔获得百分比。
- 30天随访DUS识别残余/再狭窄>70%,临床随访确定改善发生率、cdTLR、开放手术需求及截肢。
主要发现
- 患者因Rutherford 3-5级缺血接受治疗,156条肢体共治疗260处病变,包括51处支架内再狭窄和55处完全闭塞。
- 中位管腔获得为26.4%(四分位距23;31)%,胫动脉显著高于股腘动脉(P=0.009)。
- 股腘动脉病变中46处(22.2%)需要支架置入,胫动脉段无支架置入。
- 30天DUS评估>70%狭窄存在于2.3%的治疗病变中。
关键数值与推荐
- 干预指征:症状(Rutherford 3-6级)联合IVUS评估的70%面积狭窄病变。
- 中位管腔获得26.4%(四分位距23;31)%,胫动脉高于股腘动脉(P=0.009)。
- 30天DUS评估>70%狭窄存在于2.3%的治疗病变中。
- cdTLR风险比1.006(95%置信区间0.978-1.036),P=0.660。
临床怎么用
- 斑块旋切可作为下肢血运重建中可预期获得约26%管腔面积增加的工具,尤其胫动脉管腔获得更显著。
- 本系列中支架使用率较低,胫动脉段可避免支架置入。
- 管腔获得程度不宜单独作为cdTLR的预测指标,应关注初始闭塞、病变长度及支架内再狭窄。
- 术后30天DUS可用于筛查残余/再狭窄>70%的高风险病变。
局限性
- 单中心前瞻性观察性研究,缺乏对照组。
- 随访时间较短(平均15.2±3.3个月),中期结果需更长期验证。
- 管腔获得范围较窄,可能限制对其与cdTLR关系的统计效能。
- 不同斑块旋切装置间比较非随机,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While atherectomy is commonly used in peripheral vascular interventions, multiplanar data regarding the degree of luminal gain from the atherectomy procedure itself is lacking. We assessed immediate percent luminal gain, measured by intravascular ultrasound (IVUS) in different atherectomy devices. We also evaluated short-term patency measured by duplex ultrasound (DUS) and mid-term clinical follow-up. METHODS: We prospectively collected data on 156 consecutive lower extremity revascularizations for 145 unique patients (11 bilateral staged interventions). Atherectomy was always followed by balloon angioplasty, with selective use of stenting. Indications for intervention were symptoms (Rutherford class 3-6) combined with lesions 70% area stenosis assessed by IVUS. IVUS also identified lesion length, calcification, and percent stenosis pre- and immediately post-atherectomy. This difference represented percent luminal gain by atherectomy alone. Follow-up DUS was performed at 30 days to identify residual/recurrent stenosis > 70%. Patients were followed up clinically to determine incidence of improvement, clinically driven target lesion revascularizations (cdTLRs), need for open surgery, and amputations. RESULTS: Patients were treated for Rutherford class 3-5 ischemia. Two hundred sixty (260) lesions were treated in 156 limbs, including 51 in-stent restenosis (ISR) and 55 total occlusions. Two hundred nine (80.1%) lesions were in femoral-popliteal distribution. Median luminal gain was 26.4 (interquartile range 23; 31) % and was significantly higher in tibial than femoral-popliteal vessels (P = 0.009). Stenting was required in 46 (22.2%) of femoral-popliteal lesions and no tibial segments. Stenosis > 70% assessed by DUS at 30 days was present in 2.3% of treated lesions. Mean follow-up was 15.2 ± 3.3 months. CdTLR was performed in 53 cases (34%), including 3 (1.9%) open revascularization and major amputation in 2 (1.3%) legs, both Rutherford Class 4-5. Due to the tight range of luminal gain across all procedures, we saw no effect of the degree of luminal gain on the occurrence or timing of cdTLR (hazard ratio 1.006 (95% confidence interval 0.978-1.036), P = 0.660). CdTLR was related to initial presence of occlusion, lesion length, and ISR as the initial indication for intervention. CONCLUSION: Atherectomy consistently results in median luminal gain of 26.4%, which is similar between different atherectomy devices and depends on the baseline vessel size. In this series stent placement was infrequent, with no stents placed in the tibial position. CdTLR was not influenced by degree of calcification or percent luminal gain attributed to atherectomy. There was improvement in the majority of patients across all Rutherford categories, with a low rate of open intervention and amputation, which was restricted to patients with chronic limb-threatening ischemia.
引用
- Proczka MS, Forman JD, Maldonado EJ, et al. Luminal Gain after Atherectomy Measured by Intravascular Ultrasound (IVUS) and Impact on Mid-Term Results. Ann Vasc Surg. 2025. PMID: 40816485. doi:10.1016/j.avsg.2025.07.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。